BEIJING, Sept. 9 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems, Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing, and sale of medical devices and homecare medical products in China, announced today that it has retained RedChip Companies, Inc. to lead its public and investor relations programs.
"We have heard nothing but positive reports about RedChip's track record of increasing investor awareness and visibility for emerging growth companies in the small cap space," said Mr. Ping Chen, CEO of Dehaier Medical Systems. "We are excited to have the RedChip team heading our investor relations program and providing guidance and input. We are certain that RedChip's strong investor network and public relations platform will increase our visibility and help us reach a broader investor audience."
"We are pleased to have the opportunity to represent Dehaier Medical," said Dave Gentry, President and CEO of RedChip Companies, Inc. "As China's population continues to age, the number of people over the age of 60 is expected to grow at a rate of 6 million per year, creating an enormous long-term potential market for companies like Dehaier. The Company's ongoing relationships with thousands of distributors and hospitals across China put it in a strong position competitively to become one of the dominant medical device distributors in the country. We look forward to implementing our comprehensive investor and public relations program and introducing Dehaier Medical to our extensive network of investors."
About Dehaier Medical Systems Ltd.
Dehaier Medical Systems is an emerging leader in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare medical products. The Company develops and assembles its own branded products from third-party components. The Company also distributes products designed and manufactured by other companies, including medical devices and respiratory and oxygen homecare products from IMD (Italy), Welch Allyn (USA), Penlon (UK), HEYER (Germany), Timesco (UK), ResMed (Australia) and JMS (Japan). Dehaier's technology is based on two patents, five pending patents, and proprietary technology. More information may be found at http://www.chinadhr.com .
About RedChip Companies, Inc.
RedChip Companies is an international, small-cap research and financial public relations firm headquartered in Orlando, Florida; with affiliate offices in Beijing, China; Paris, France; and Seoul, Korea. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research(TM), Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Small-Cap TV(TM), Shareholder Intelligence, Social Media and Blogging Services, Webcasts, and RedChip Radio(TM). To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/productsandservices.asp .
The above news release contains forward-looking statements. The statements contained in this document that are not statements of historical fact, including but not limited to, statements identified by the use of terms such as "anticipate," "appear," "believe," "could," "estimate," "expect," "hope," "indicate," "intend," "likely," "may," "might," "plan," "potential," "project," "seek," "should," "will," "would," and other variations or negative expressions of these terms, including statements related to expected market trends and the Company's performance, are all "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve a number of risks and uncertainties. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performances, and are subject to a wide range of external factors, uncertainties, business risks, and other risks identified in filings made by the company with the Securities and Exchange Commission. Actual results may differ materially from those indicated by such forward-looking statements. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statement contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances upon which any statement is based.
For more information, please contact: At the company: Gui Shuguang Dehaier Medical Systems Ltd. Phone: +86-10-5166-0080 x169 Email: firstname.lastname@example.org Investor relations: Dave Gentry RedChip Companies, Inc. Phone: 1-800-733-2447 x104 Email: email@example.com Web: http://www.RedChip.com
|SOURCE Dehaier Medical Systems Ltd.|
Copyright©2010 PR Newswire.
All rights reserved